SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 18.64 |
| Enterprise Value ($M) | -6.30 |
| Book Value ($M) | 23.26 |
| Book Value / Share | 4.28 |
| Price / Book | 0.80 |
| NCAV ($M) | 22.85 |
| NCAV / Share | 4.20 |
| Price / NCAV | 0.82 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.58 |
| Return on Assets (ROA) | -0.60 |
| Return on Equity (ROE) | -0.74 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.28 |
| Current Ratio | 7.28 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 26.48 |
| Assets | 26.89 |
| Liabilities | 3.64 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Stonepine Capital Management, LLC | 6.60 | ||
| 13G | Sio Capital Management, LLC | 7.49 | ||
| 13G/A | Hirschman Orin | 9.40 | 1.25 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 9,932 | 20,282 | 48.97 | |
| 549 | 8,354 | 6.57 | |
| 340 | 8,152 | 4.17 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ANEB – Anebulo Pharmaceuticals, Inc. | ANIX – Anixa Biosciences, Inc. |
| APM – Aptorum Group Limited | APTO – Aptose Biosciences Inc. |
| APVO – Aptevo Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io